Solid Biosciences (SLDB) PT Raised to $18 at Piper Sandler

May 13, 2026 7:22 AM

Piper Sandler analyst Biren Amin raised the price target on Solid Biosciences (NASDAQ: SLDB) to $18.00 (from $17.00) while maintaining a Overweight rating.

No results found